| Literature DB >> 28690877 |
Julia Münch1, Ralf Matthias Hagen2, Martin Müller3, Viktor Kellert4, Dorothea Franziska Wiemer5, Rebecca Hinz6, Norbert Georg Schwarz7, Hagen Frickmann5,8.
Abstract
The effectiveness of a disinfectant-based decolonization strategy for multidrug-resistant bacteria like extended spectrum β-lactamase (ESBL)-positive Gram-negative bacteria with or without additional fluoroquinolon and carbapenem resistance as well as vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus was assessed. Between 2011 and 2015, 25 patients from Libya, Syria, and the Ukraine with war traumata were treated at the Bundeswehr hospital Hamburg. The patients were heavily colonized and infected with multidrug-resistant bacteria, altogether comprising 371 distinct combinations of pathogens and isolation sites. Local disinfection was assessed for effectiveness regarding successful decolonization of multidrug-resistant bacteria. Altogether, 170 cases of successful decolonization were observed, comprising 95 (55.8%) such events at sampling sites that were accessible to disinfecting procedures. The remaining 75 (44.2%) decolonization events had to be considered as spontaneous. In contrast, 95 out of 172 (55.2%) colonized isolation sites that were accessible to disinfection procedures were successfully decolonized. Patient compliance with the enforced hygiene procedures was associated with decolonization success. Systemic antibiotic therapy did not relevantly affect isolation time. Disinfecting washing moderately supports local decolonization of multidrug-resistant pathogens in comparison with spontaneous decolonization rates if the patients' compliance with the applied hygiene procedures is ensured.Entities:
Keywords: ESBL; MRSA; VRE; carbapenem resistance; decolonization; multidrug-resistant bacteria; war injuries
Year: 2017 PMID: 28690877 PMCID: PMC5495082 DOI: 10.1556/1886.2017.00008
Source DB: PubMed Journal: Eur J Microbiol Immunol (Bp) ISSN: 2062-509X
Characterization of the study population
| Country | Number ( | Gender | Age (years) ± SD | Main diagnoses | Percentage of patients with systemic antibiotic therapy (%) | Observed clinical outcomes (%) |
|---|---|---|---|---|---|---|
| Libya | 6 | Male | 32.2 ± 3.8 | Gun shot injury ( | 0 | 100 dismissal |
| Syria | 9 | Male | 25.1 ± 4.9 | Gun shot injury ( | 0 | 77.7 dismissal, |
| Ukraine | 10 | Male | 27.7 ± 7.8 | Gun shot injury ( | 70 | 70.0 dismissal, |
| Total | 25 | Male | 27.8 ± 6.4 | 28 | 80.0 dismissal, |
Explanation of observed clinical outcomes: *1: n = 1 got transferred to another hospital and escaped before dismissal, n = 1 disappeared somewhere in Germany without an official dismissal
*2: n = 1 was sent back home because of aggressive behavior towards nursing staff, n = 1 was still hospitalized at the time-point of data acquisition
*3: referring to *1 and *2 (n = 4)
Characterization of isolation events of multidrug resistant (MDR) bacteria
| ESBL/2MRGN ( | |||||
| Species | Isolation site(s) | Percentage of presumed infections | Days in hospital until first isolation (mean ± SD) | Percentage of successful decolonization | Percentage of successful decolonization proven by 3 negative swabs |
| Inguinal ( | 4.6 | 21.2 ± 17.3 | 68.2 | 18.2 | |
| Perianal ( | |||||
| ( | Nose ( | ||||
| Rectal ( | |||||
| Pharynx ( | |||||
| Gluteal ( | |||||
| Wound ( | |||||
| Perianal ( | 47.4 | 10.7 ± 22.4 | 63.2 | 5.3 | |
| ( | Abdomen ( | ||||
| Urine ( | |||||
| Wound ( | |||||
| Inguinal ( | |||||
| Gluteal ( | |||||
| Rectal ( | |||||
| Artificial anus ( | |||||
| Suprapubic catheter ( | |||||
| Perianal ( | 75.0 | 15.5 ± 10.4 | 75.0 | 0 | |
| Wound ( | |||||
| ( | Elbow ( | ||||
| Perianal ( | 0 | 4.0 ± 4.2 | 0 | 0 | |
| Inguinal ( | |||||
| 3MRGN ( | |||||
| Species | Isolation site(s) | Percentage of presumed infections | Days in hospital until first isolation (mean ± SD) | Percentage of successful decolonization | Percentage of successful decolonization proven by 3 negative swabs |
| Perianal ( | 36.2 | 26.1 ± 25.7 | 46.4 | 10.1 | |
| Inguinal ( | |||||
| ( | Rectal ( | ||||
| Nose ( | |||||
| Upper leg ( | |||||
| Pharynx ( | |||||
| Armpit ( | |||||
| Urine ( | |||||
| Abdominal deep ( | |||||
| Deep shoulder ( | |||||
| Gluteal ( | |||||
| Artificial anus ( | |||||
| Wound ( | |||||
| Lower leg ( | |||||
| Chest ( | |||||
| Forehead ( | |||||
| External nose ( | |||||
| Abdominal ( | |||||
| Shoulder ( | |||||
| Mesh graft ( | |||||
| Blood culture ( | |||||
| Bowel ( | |||||
| Tracheal secretion ( | |||||
| Central venous catheter ( | |||||
| Perianal ( | 53.1 | 34.2 ± 39.6 | 46.9 | 6.3 | |
| Urine ( | |||||
| Rectal ( | |||||
| Gluteal ( | |||||
| Inguinal ( | |||||
| Abdomen ( | |||||
| Suprapubic catheter ( | |||||
| Artificial anus ( | |||||
| Pharynx ( | |||||
| Nose ( | |||||
| Forehead ( | |||||
| Fistula ( | |||||
| Tibia ( | |||||
| Lower leg ( | |||||
| Perianal ( | 82.8 | 18.3 ± 19.6 | 62.1 | 0 | |
| Inguinal ( | |||||
| ( | Rectal ( | ||||
| Nose ( | |||||
| Wound ( | |||||
| Knee ( | |||||
| Upper leg ( | |||||
| Pharynx ( | |||||
| Lower leg ( | |||||
| Tibia ( | |||||
| Gluteal ( | |||||
| Heel deep ( | |||||
| Knee deep ( | |||||
| Elbow deep ( | |||||
| Left eye ( | |||||
| Upper leg ( | 55.6 | 23.0 ± 27.0 | 77.8 | 11.1 | |
| Rectal ( | |||||
| ( | Perianal ( | ||||
| Forehead ( | |||||
| Artificial anus ( | |||||
| Suprapubic catheter ( | |||||
| Wound ( | 66.7 | 10.8 ± 11.0 | 83.3 | 0 | |
| Perianal ( | |||||
| ( | Superficial shoulder ( | ||||
| Humerus intra-operative ( | |||||
| Perianal ( | 50.0 | 13.5 ± 10.9 | 100 | 0 | |
| Superficial shoulder ( | |||||
| ( | Deep shoulder ( | ||||
| Inguinal ( | |||||
| Humerus intra-operative ( | |||||
| Shoulder ( | 33.3 | 27.3 ± 15.9 | 83.3 | 3.4 | |
| Deep shoulder ( | |||||
| ( | Upper leg ( | ||||
| Lower leg ( | |||||
| Perianal ( | |||||
| Rectal ( | |||||
| Inguinal ( | 0 | 35.6 ± 20.6 | 60.0 | 0 | |
| ( | Nose ( | ||||
| Rectal ( | |||||
| Perianal ( | |||||
| Heel deep ( | 50.0 | 18.5 ± 24.7 | 50.0 | 0 | |
| Upper leg ( | |||||
| Rectal ( | 0 | 5.0 ± 0 | 100 | 0 | |
| Artificial anus ( | |||||
| Inguinal ( | 0 | 10.0 ± (–) | 100 | 0 | |
| ( | |||||
| Nose ( | 0 | 253.0 ± (–) | 100 | 0 | |
| 4MRGN ( | |||||
| Species | Isolation site(s) | Percentage of presumed infections | Days in hospital until first isolation (mean ± SD) | Percentage of successful decolonization | Percentage of successful decolonization proven by 3 negative swabs |
| Inguinal ( | 54.7 | 8.5 ± 13.0 | 64.2 | 3.8 | |
| Perianal ( | |||||
| ( | Upper leg ( | ||||
| Forehead ( | |||||
| Armpit ( | |||||
| Elbow ( | |||||
| Lower leg ( | |||||
| Nose ( | |||||
| Pharynx ( | |||||
| Gluteal ( | |||||
| External fixator ( | |||||
| Rectal ( | |||||
| Wound ( | |||||
| Chest ( | |||||
| Knee ( | |||||
| Tibia ( | |||||
| Forearm ( | |||||
| Heel ( | |||||
| Lower abdomen ( | |||||
| Suprapubic catheter ( | |||||
| Tracheal secretion ( | |||||
| Inguinal ( | 37.5 | 23.2 ± 30.7 | 50.0 | 10.0 | |
| Perianal ( | |||||
| ( | Upper leg ( | ||||
| Nose ( | |||||
| Pharynx ( | |||||
| Rectal ( | |||||
| Urine ( | |||||
| Blood culture ( | |||||
| Lower leg ( | |||||
| Abdominal ( | |||||
| Abdominal deep ( | |||||
| Tracheal secretion ( | |||||
| Shoulder deep ( | |||||
| Gluteal ( | |||||
| Intra-operative swab ( | |||||
| Tracheostomy ( | |||||
| Epidural catheter ( | |||||
| Artificial anus ( | |||||
| Upper leg ( | 57.5 | 14.7 ± 24.9 | 45.0 | 10.0 | |
| Pharynx ( | |||||
| ( | Inguinal ( | ||||
| Perianal ( | |||||
| Urine ( | |||||
| Armpit ( | |||||
| Nose ( | |||||
| Gluteal ( | |||||
| Forearm ( | |||||
| Wrist ( | |||||
| Hip ( | |||||
| Lower leg ( | |||||
| Chest ( | 57.5 | 14.7 ± 24.9 | 45.0 | 10.0 | |
| Forehead ( | |||||
| ( | External nose ( | ||||
| Abdomen ( | |||||
| Heel ( | |||||
| Abdominal deep ( | |||||
| Femoral shaft ( | |||||
| Rectal ( | |||||
| Artificial anus ( | |||||
| Central venous catheter ( | |||||
| Inguinal ( | 33.3 | 9.0 ± 7.0 | 33.0 | 0 | |
| Perianal ( | |||||
| Urine ( | |||||
| Upper leg ( | 100 | 18.5 ± 24.7 | 0 | 0 | |
| External fixator ( | |||||
| Nose ( | 0 | 27.0 ± (–) | 100 | 0 | |
| MRSA ( | |||||
| Species | Isolation site(s) | Percentage of presumed infections | Days in hospital until first isolation (mean ± SD) | Percentage of successful decolonization | Percentage of successful decolonization proven by 3 negative swabs |
| Nose ( | 60.0 | 37 ± 48.9 | 26.6 | 13.3 | |
| Pharynx ( | |||||
| Knee ( | |||||
| Tibia right ( | |||||
| Lower leg ( | |||||
| Upper leg ( | |||||
| Forearm ( | |||||
| Elbow deep ( | |||||
| Shoulder ( | |||||
| Shoulder deep ( | |||||
| Perianal ( | |||||
| rectal ( | |||||
| VRE | |||||
| Species | Isolation site(s) | Percentage of presumed infections | Days in hospital until fi rst isolation (mean ± SD) | Percentage of successful decolonization | Percentage of successful decolonization proven by 3 negative swabs |
| Enterococcus | Pharynx (n = 1) | 0 | 32.5 ± 4.9 | 0 | 0 |
Characterization of successful decolonization events
| Number of successful colonization events per species | Recolonization with the strain after initial successful decolonization (defined as intermitting negative screening results) (%) | Number of days between first isolation and successful decolonization (negative swabbing result without later reoccurring), mean ± standard deviation (SD) |
|---|---|---|
| 5.9 | 35.5 ± 28.7 | |
| 0 | 36.2 ± 23.5 | |
| 0 | 32.5 ± 20.3 | |
| 5.6 | 41.6 ± 33.9 | |
| 10 | 37.1 ± 41.9 | |
| 0 | 28.0 ± 0 | |
| 17.8 | 48.8 ± 73.8 | |
| 14.3 | 54.5 ± 51.4 | |
| 0 | 29.7 ± 13.8 | |
| 0 | 13.0 ± 0 | |
| 17.4 | 82.9 ± 100.4 | |
| 0 | 31.5 ± 4.9 | |
| 50.0 | 39.3 ± 49.2 | |
| Total ( | 11.8 | 46.3 ± 59.2 |
Association between decolonization success and patient compliance with decolonization procedures. Only isolates from the skin, pharyngeal mucous membrane, and superficial wounds that were affected by the decolonization procedures were included in the assessment
| Species and groups | Compliance (mean ± standard deviation (SD)) in cases of successful decolonization | Compliance (mean ± standard deviation (SD)) in cases without decolonization success | Significance level ( | Percent of successful decolonization (%) |
|---|---|---|---|---|
| 6.4 ± 1.8 | 4.8 ± 2.6 | 0.06 | 57.9 (22/38) | |
| 6.0 ± 1.4 | – ( | Not applicable | 100 (2/2) | |
| 6.3 ± 2.9 | – ( | Not applicable | 100 (3/3) | |
| 4.8 ± 1.6 | 3.7 ± 2.2 | 0.21 | 57.1 (8/14) | |
| – ( | 7.0 ( | Not applicable | 0 (0/1) | |
| 6.1 ± 1.6 | 6.2 ± 1.8 | 0.95 | 57.1 (8/14) | |
| 8.0 ( | – ( | Not applicable | 100 (1/1) | |
| 6.7 ± 1.5 | 6.0 ± 1.9 | 0.20 | 57.1 (28/49) | |
| 8.0 ( | 7.0 ( | Not applicable | 75.0 (1/4) | |
| 7.0 ( | 7.0 ( | Not applicable | 66.7 (2/3) | |
| 7.0 ( | – ( | Not applicable | 100 (1/1) | |
| 7.3 ± 1.5 | 5.6 ± 2.9 | 0.18 | 50 (16/32) | |
| – ( | – ( | Not applicable | Not applicable | |
| 7.0 ( | 4.2 ± 1.9 | Not applicable | 10 (1/10) | |
| MRGN 2-4 | 6.6 ± 1.7 | 5.5 ± 2.4 | 58.4 (94/161) | |
| Gram-positive bacteria ( | 7.0 ( | 4.2 ± 2.0 | Not applicable | 9.1 (1/11) |
| Total | 6.6 ± 1.7 | 5.3 ± 2.3 | 55.2 (95/172) |
Association of recolonization events with cohort isolation with patients carrying the same species
| Species | Resistance type | Number of recolonization events ( | Percentage of cases with a patient colonized with the same pathogen in the same room (%) | Percentage of cases with a patient colonized with the same pathogen on the same ward (%) |
|---|---|---|---|---|
| 4MRGN | 2 | 0 | 100 | |
| 3MRGN | 2 | 0 | 100 | |
| 3MRGN ESBL | 1 | Not applicable | Not applicable | |
| 3MRGN | 4 | 0 | 75.0 | |
| 3MRGN ESBL | 2 | 0 | 100 | |
| ESBL | 1 | Not applicable | Not applicable | |
| 3MRGN | 2 | 0 | 100 | |
| 3MRGN ESBL | 4 | 0 | 100 | |
| 4MRGN | 7 | 42.9 | 85.7 | |
| 4MRGN ESBL | 1 | Not applicable | Not applicable | |
| 3MRGN | 1 | Not applicable | Not applicable | |
| 3MRGN | 1 | Not applicable | Not applicable | |
| 4MRGN | 10 | 0 | 100 | |
| MRSA | 8 | 0 | 87.5 |
Factors affecting the decolonization success
| Failed decolonization | Successful decolonization | Early decolonization (number of days until decolonization ≤ median (28) of the assessed cases) | Late decolonization (number of days until decolonization > median (28) of the assessed cases) | Cases with recolonization events | |
|---|---|---|---|---|---|
| Total ( | 77/172 (44.8 %) | 95/172 (55.2%) | 54/172 (31.4%) | 41/172 (23.8%) | 26/172 (15.1%) |
| MRSA ( | 9/10 (90.0%) | 1/10 (10.0%) | 0/10 (0%) | 1/10 (50.0%) | 6/10 (60.0%) |
| VRE ( | 1/1 (100%) | 0/1 (0%) | 0/1 (0%) | 0/1 (0%) | 0/1 (0%) |
| Gram-negative bacteria ( | 67 /161 (41.6%) | 94/161 (58.4%) | 54/161 (33.5%) | 41/161 (25.5%) | 20/161 (12.4%) |
| Pharynx ( | 9/18 (50.0%) | 9/18 (50.0%) | 7/18 (38.9%) | 2/18 (11.1%) | 8/18 (44.4%) |
| Nostrils ( | 6/21 (28.6%) | 15/21 (71.4%) | 6/21 (28.6%) | 9/21 (42.9%) | 5/21 (23.8%) |
| Skin ( | 36/68 (52.9%) | 32/68 (47.1%) | 21/68 (30.9%) | 11/68 (16.2%) | 5/68 (7.4%) |
| Superficial wounds ( | 26/65 (40.0%) | 39/65 (60.0%) | 20/65 (30.8%) | 19/65 (29.2%) | 8/65 (12.3%) |
| Systemic antibiotic therapy applied ( | 59/113 (52.2%) | 54/113 (47.8%) | 22/113 (19.5%) | 32/113 (28.3%) | 20/113 (17.7%) |
Association of antibiotic therapy and first isolation >72 h after hospital admission
| (Total = 310) | Number of isolation events without antibiotic therapy | Number of isolation events with antibiotic therapy |
|---|---|---|
| First isolation ≤72 h after hospital admission | 48 | 66 |
| First isolation >72 h after hospital admission | 79 | 117 |
P = 0.81 (Fischer’s exact test, two-sided)